Postoperative Pain Management Study
common.study.values.description
“Exparel Use in Bilateral TAP Blocks for Postoperative Pain Control”
To determine if Exparel (Liposomal Bupivacaine, an FDA approved drug) use in ultrasound guided Transversus Abdominis Plane (TAP) blocks may reduce opioid requirement use postoperatively, reduce pain scores postoperatively, reduce incidence of nausea in the postop period, and decrease length of hospital stay
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Exparel 266 MG Per 20 ML Injection
patients receive Exparel in bilateral TAP blocks for open abdomen surgery
participant.views.study.view.additional
participant.views.study.view.scientific-title
The Use of Exparel (Liposomal Bupivacaine) for Bilateral TAP (Transversus Abdominis Plane) Blocks in Open Abdomen Surgery for Postoperative Pain Control
common.study.values.clinical-trial-id
NCT03878888
participant.views.study.view.id
b2krWd
